Clinical-stage immuno-oncology company Forty Seven Inc. announced a collaboration with Acerta Pharma, AstraZeneca’s hematology research and development center of excellence.
https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png00GlobeNewswirehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngGlobeNewswire2019-05-10 08:01:422019-05-10 14:03:51Forty Seven Inc. and Acerta Enter Collaboration
